Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ATG9A | Human | (+)-schisandrin B | multiple interactions | ISO | Atg9a (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATG9A mRNA] | CTD | PMID:31150632 | ATG9A | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Atg9a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATG9A mRNA | CTD | PMID:36331819 | ATG9A | Human | 2,3',4,4',5-Pentachlorobiphenyl | multiple interactions | ISO | Atg9a (Rattus norvegicus) | 6480464 | 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [2 more ... | CTD | PMID:32895711 | ATG9A | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32895711 | ATG9A | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ATG9A mRNA | CTD | PMID:21215274 | ATG9A | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Atg9a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATG9A mRNA | CTD | PMID:24680724 | ATG9A | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Atg9a (Mus musculus) | 6480464 | bisphenol S affects the methylation of ATG9A gene | CTD | PMID:31683443 | ATG9A | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ATG9A mRNA | CTD | PMID:33167477 | ATG9A | Human | atrazine | increases expression | ISO | Atg9a (Mus musculus) | 6480464 | Atrazine results in increased expression of ATG9A mRNA | CTD | PMID:30360616 | ATG9A | Human | atrazine | multiple interactions | ISO | Atg9a (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in increased expression of ATG9A mRNA] | CTD | PMID:30360616 | ATG9A | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ATG9A protein | CTD | PMID:33278487 | ATG9A | Human | bisphenol A | affects expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ATG9A mRNA | CTD | PMID:25181051 | ATG9A | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ATG9A mRNA | CTD | PMID:36232920 | ATG9A | Human | bisphenol A | decreases expression | ISO | Atg9a (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ATG9A mRNA | CTD | PMID:38074096 | ATG9A | Human | bisphenol A | increases expression | ISO | Atg9a (Mus musculus) | 6480464 | bisphenol A results in increased expression of ATG9A mRNA | CTD | PMID:33221593 and PMID:35598803 | ATG9A | Human | Brodifacoum | decreases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | bromfenacoum results in decreased expression of ATG9A protein | CTD | PMID:28903499 | ATG9A | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of ATG9A protein | CTD | PMID:35688186 | ATG9A | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of ATG9A mRNA | CTD | PMID:30871063 | ATG9A | Human | colistin | increases expression | ISO | Atg9a (Mus musculus) | 6480464 | Colistin results in increased expression of ATG9A mRNA | CTD | PMID:35378205 | ATG9A | Human | coumarin | decreases phosphorylation | EXP | | 6480464 | coumarin results in decreased phosphorylation of ATG9A protein | CTD | PMID:35688186 | ATG9A | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of ATG9A mRNA | CTD | PMID:37042841 | ATG9A | Human | dibutyl phthalate | decreases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of ATG9A mRNA | CTD | PMID:21266533 | ATG9A | Human | dieldrin | increases response to substance | EXP | | 6480464 | ATG9A gene mutant form results in increased susceptibility to Dieldrin | CTD | PMID:32421776 | ATG9A | Human | dioxygen | multiple interactions | EXP | | 6480464 | Oxygen deficiency promotes the reaction [HIF1A protein binds to ATG9A promoter] | CTD | PMID:23880069 | ATG9A | Human | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of ATG9A mRNA | CTD | PMID:19244175 | ATG9A | Human | epoxiconazole | decreases expression | ISO | Atg9a (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ATG9A mRNA | CTD | PMID:35436446 | ATG9A | Human | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of ATG9A protein | CTD | PMID:20621659 | ATG9A | Human | folic acid | decreases expression | ISO | Atg9a (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ATG9A mRNA | CTD | PMID:25629700 | ATG9A | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of ATG9A protein | CTD | PMID:37730182 | ATG9A | Human | gentamycin | increases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of ATG9A mRNA | CTD | PMID:33387578 | ATG9A | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of ATG9A protein | CTD | PMID:32959892 | ATG9A | Human | leflunomide | increases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | leflunomide results in increased expression of ATG9A mRNA | CTD | PMID:24136188 | ATG9A | Human | lycopene | multiple interactions | ISO | Atg9a (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in increased expression of ATG9A mRNA] | CTD | PMID:30360616 | ATG9A | Human | nefazodone | decreases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | nefazodone results in decreased expression of ATG9A mRNA | CTD | PMID:24136188 | ATG9A | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ATG9A mRNA | CTD | PMID:35430440 | ATG9A | Human | paracetamol | increases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of ATG9A mRNA | CTD | PMID:33387578 | ATG9A | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Atg9a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATG9A mRNA | CTD | PMID:36331819 | ATG9A | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of ATG9A protein | CTD | PMID:26879310 | ATG9A | Human | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of ATG9A mRNA | CTD | PMID:19244175 | ATG9A | Human | SKF-96365 hydrochloride | multiple interactions | ISO | Atg9a (Rattus norvegicus) | 6480464 | 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [2 more ... | CTD | PMID:32895711 | ATG9A | Human | sodium arsenite | multiple interactions | ISO | Atg9a (Mus musculus) | 6480464 | [sodium arsenite co-treated with Dietary Fats] results in increased expression of ATG9A mRNA | CTD | PMID:30097599 | ATG9A | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of ATG9A mRNA | CTD | PMID:38568856 | ATG9A | Human | sodium arsenite | increases expression | ISO | Atg9a (Mus musculus) | 6480464 | sodium arsenite results in increased expression of ATG9A mRNA | CTD | PMID:30097599 | ATG9A | Human | tetrachloromethane | multiple interactions | ISO | Atg9a (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATG9A mRNA] | CTD | PMID:31150632 | ATG9A | Human | tetrachloromethane | decreases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of ATG9A mRNA | CTD | PMID:31150632 | ATG9A | Human | thioacetamide | decreases expression | ISO | Atg9a (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ATG9A mRNA | CTD | PMID:34492290 | ATG9A | Human | triptonide | increases expression | ISO | Atg9a (Mus musculus) | 6480464 | triptonide results in increased expression of ATG9A mRNA | CTD | PMID:33045310 | ATG9A | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of ATG9A mRNA | CTD | PMID:28818685 | ATG9A | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of ATG9A gene | CTD | PMID:29154799 | |